These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 30692096)
1. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer. Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096 [TBL] [Abstract][Full Text] [Related]
2. Molecular and clinicopathological features of appendiceal mucinous neoplasms. Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969 [TBL] [Abstract][Full Text] [Related]
3. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093 [TBL] [Abstract][Full Text] [Related]
4. Mutation profile of high-grade appendiceal mucinous neoplasm. Liao X; Vavinskaya V; Sun K; Hao Y; Li X; Valasek M; Xu R; Polydorides AD; Houldsworth J; Harpaz N Histopathology; 2020 Feb; 76(3):461-469. PubMed ID: 31491041 [TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835 [TBL] [Abstract][Full Text] [Related]
6. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix. Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197 [TBL] [Abstract][Full Text] [Related]
8. KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation Sequencing. Matson DR; Xu J; Huffman L; Barroilhet L; Accola M; Rehrauer WM; Weisman P Am J Case Rep; 2017 May; 18():558-562. PubMed ID: 28526814 [TBL] [Abstract][Full Text] [Related]
9. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival. Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222 [TBL] [Abstract][Full Text] [Related]
10. Toward the molecular dissection of peritoneal pseudomyxoma. Pietrantonio F; Perrone F; Mennitto A; Gleeson EM; Milione M; Tamborini E; Busico A; Settanni G; Berenato R; Caporale M; Morano F; Bossi I; Pellegrinelli A; Di Bartolomeo M; de Braud F; Baratti D; Bowne WB; Kusamura S; Deraco M Ann Oncol; 2016 Nov; 27(11):2097-2103. PubMed ID: 27502722 [TBL] [Abstract][Full Text] [Related]
11. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma. Kim H; Kim BH; Lee D; Shin E Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926 [TBL] [Abstract][Full Text] [Related]
14. Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review. Stein A; Strong E; Clark Gamblin T; Clarke C; Tsai S; Thomas J; George B; Mogal H Ann Surg Oncol; 2020 Jan; 27(1):85-97. PubMed ID: 31583543 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics. Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948 [TBL] [Abstract][Full Text] [Related]
16. High-level microsatellite instability in appendiceal carcinomas. Taggart MW; Galbincea J; Mansfield PF; Fournier KF; Royal RE; Overman MJ; Rashid A; Abraham SC Am J Surg Pathol; 2013 Aug; 37(8):1192-200. PubMed ID: 23648460 [TBL] [Abstract][Full Text] [Related]
17. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component. Li X; Sun K; Liao X; Gao H; Zhu H; Xu R BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877 [TBL] [Abstract][Full Text] [Related]